These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 21733370

  • 1. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 3. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
    Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ.
    Climacteric; 2011 Aug 20; 14(4):472-81. PubMed ID: 21469973
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
    Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL.
    Menopause; 2005 Aug 20; 12(6):716-27. PubMed ID: 16278615
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K.
    Menopause; 2014 Mar 20; 21(3):227-35. PubMed ID: 23963307
    [Abstract] [Full Text] [Related]

  • 6. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 20; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 8. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Oct 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
    White WB, Pitt B, Preston RA, Hanes V.
    Circulation; 2005 Sep 27; 112(13):1979-84. PubMed ID: 16186434
    [Abstract] [Full Text] [Related]

  • 12. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun 27; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 13. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K.
    Menopause; 2006 Jun 27; 13(1):130-8. PubMed ID: 16607109
    [Abstract] [Full Text] [Related]

  • 14. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun 27; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct 27; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 20. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH, Beijers-De Bie L, Vihtamaki T, Tuimala R, Siseles N, Magaril C, The HS, Houben PW, Murga M, Spielmann D, De Villiers TJ.
    Gynecol Endocrinol; 2001 Oct 27; 15(5):349-58. PubMed ID: 11727357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.